Taher AT, Weatherall DJ, Cappellini MD. Thalassaemia. Lancet. 2018;391(10116):155–67.
Jalil T, Yousafzai YM, Rashid I, Ahmed S, Ali A, Fatima S, et al. Mutational analysis of beta thalassaemia by multiplex ARMS-PCR in Khyber Pakhtunkhwa, Pakistan. J Ayub Med Coll Abbottabad. 2019;31(1):98–103.
Goh LPW, Chong ETJ, Lee P-C. Prevalence of alpha (α)-thalassemia in Southeast Asia (2010–2020): a meta-analysis involving 83,674 subjects. Int J Environ Res Public Health. 2020;17(20):7354.
PubMed PubMed Central Google Scholar
Demosthenous C, Vlachaki E, Apostolou C, Eleftheriou P, Kotsiafti A, Vetsiou E, et al. Beta-thalassemia: renal complications and mechanisms: a narrative review. Hematology. 2019;24(1):426–38.
KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2024;105(4s):S117-314. https://doi.org/10.1016/j.kint.2023.10.018.
Joher N, Matignon M, Grimbert P. HLA desensitization in solid organ transplantation: anti-CD38 to across the immunological barriers. Front Immunol. 2021;12: 688301.
CAS PubMed PubMed Central Google Scholar
Emam M, Moneem MA, Gheith O, Mahmoud T, Nagib AM, Abdultawab K, et al. Successful kidney transplantation of a patient with thalassemia major: case report and review of literature. J Egypt Soc Nephrol Transplant. 2021;21(3):144–7.
Kalamara T-VN, Zarkada EG, Kasimatis ED, Kofinas AG, Klonizakis PI, Vlachaki EC. Kidney transplantation in an adult with transfusion-dependent beta thalassemia: a challenging case report and literature review. Arch Clin Cases. 2023;10(2):97.
PubMed PubMed Central Google Scholar
Sleiman J, Tarhini A, Taher AT. Renal complications in thalassemia. Thalassemia Rep. 2018;8(1):74–81.
Quinn CT, Johnson VL, Kim HY, Trachtenberg F, Vogiatzi MG, Kwiatkowski JL, et al. Renal dysfunction in patients with thalassaemia. Br J Haematol. 2011;153(1):111–7. https://doi.org/10.1111/j.1365-2141.2010.08477.x.
Article CAS PubMed PubMed Central Google Scholar
Haddad A, Tyan P, Radwan A, Mallat N, Taher A. Β-thalassemia intermedia: a bird’s-eye view. Turk J Hematol. 2014;31(1):5.
Adramerina A, Economou M. Challenges of iron chelation in thalassemic children. Thalass Rep. 2024;14(1):1–9.
Wouk N. End-stage renal disease: medical management. Am Fam Physician. 2021;104(5):493–9.
Abbas F, El Kossi M, Shaheen IS, Sharma A, Halawa A. Drug-induced myelosuppression in kidney transplant patients. Exp Clin Transplant. 2021;19(10):999–1013.
Scornik J, Meier-Kriesche H-U. Blood transfusions in organ transplant patients: mechanisms of sensitization and implications for prevention. Am J Transplant. 2011;11(9):1785–91.
Cappellini MD, Cohen A, Piga A, Bejaoui M, Perrotta S, Agaoglu L, et al. A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with β-thalassemia. Blood. 2006;107(9):3455–62.
Weinstock C, Schnaidt M. Human leucocyte antigen sensitisation and its impact on transfusion practice. Transfus Med Hemother. 2019;46(5):356–69.
PubMed PubMed Central Google Scholar
Sobiak J, Kamińska J, Głyda M, Duda G, Chrzanowska M. Effect of mycophenolate mofetil on hematological side effects incidence in renal transplant recipients. Clin Transplant. 2013;27(4):E407–14.
Datrino LN, Boccuzzi ML, Silva RM, Castilho PHBT, Riva WJ, Rocha JS, et al. Safety and efficacy of mycophenolate mofetil associated with tacrolimus for kidney-pancreas and kidney transplantation: a systematic review and meta-analysis of randomized studies. Transplant Proc. 2024;56(5):1066–76. https://doi.org/10.1016/j.transproceed.2024.05.014.
Article CAS PubMed Google Scholar
Dave V, Polkinghorne KR, Leong KG, Kanellis J, Mulley WR. Initial mycophenolate dose in tacrolimus treated renal transplant recipients, a cohort study comparing leukopaenia, rejection and long-term graft function. Sci Rep. 2020;10(1):19379. https://doi.org/10.1038/s41598-020-76379-6.
Article CAS PubMed PubMed Central Google Scholar
Nampoory MR, Johny KV, Al-Hilali N, Seshadri MS, Kanagasabhapathy AS. Erythropoietin deficiency and relative resistance cause anaemia in post-renal transplant recipients with normal renal function. Nephrol Dial Transplant. 1996;11(1):177–81.
Comments (0)